Evidence map›Paper›PMID 22069192›Full record

ArticleDevelopment (Cambridge, England)2011

ID4 regulates mammary gland development by suppressing p38MAPK activity.

Jie Dong, Shixia Huang, Marian Caikovski, Shaoquan Ji, Amanda McGrath, Myra G Custorio, Chad J Creighton, Paul Maliakkal, Ekaterina Bogoslovskaia, Zhijun Du and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation.American journal of physiology. Endocrinology and metabolism · 2017
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Jie DongLester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030, USA.
Shixia Huang
Marian Caikovski
Shaoquan Ji
Amanda McGrath
Myra G Custorio
Chad J Creighton
Paul Maliakkal
Ekaterina Bogoslovskaia
Zhijun Du
Xiaomei Zhang
Michael T Lewis
Fred Sablitzky
Cathrin Brisken
Yi Li
Baylor College of Medicine · USChildren's Cancer Center · USBioLegend (United States) · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENTP50CA058183 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI OSBORNE, C KENT · 1992 to 2012
$30.9M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Regulation of Mammary Stem CellsR01CA127857 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LEWIS, MICHAEL T. · 2008 to 2012
$1.7M
Oncogene susceptibility: physiological state & breast cell differentiationR01CA124820 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LI, YI · 2010 to 2014
$1.5M
PROGENITOR CELLS AND ONCOGENE TARGETS IN BREAST CANCERR01CA113869 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LI, YI · 2005 to 2009
$1.4M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
NCI NIH HHS CA113869NCI NIH HHS P30 CA125123NCI NIH HHS P50 CA058183NCI NIH HHS P50-CA058183NCI NIH HHS R01 CA113869NCI NIH HHS R01 CA124820NCI NIH HHS R01 CA127857NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211
6 · The paper itself

Abstract

The ID family of helix-loop-helix proteins regulates cell proliferation and differentiation in many different developmental pathways, but the functions of ID4 in mammary development are unknown. We report that mouse Id4 is expressed in cap cells, basal cells and in a subset of luminal epithelial cells, and that its targeted deletion impairs ductal expansion and branching morphogenesis as well as cell proliferation induced by estrogen and/or progesterone. We discover that p38MAPK is activated in Id4-null mammary cells. p38MAPK is also activated following siRNA-mediated Id4 knockdown in transformed mammary cells. This p38MAPK activation is required for the reduced proliferation and increased apoptosis in Id4-ablated mammary glands. Therefore, ID4 promotes mammary gland development by suppressing p38MAPK activity.

Indexed as

AnimalsApoptosisBromodeoxyuridineCell ProliferationEstradiolFemaleGene Expression Regulation, DevelopmentalImmunoblottingImmunohistochemistryInhibitor of Differentiation ProteinsIn Situ Nick-End LabelingMammary Glands, AnimalMiceMice, Inbred C57BLMice, Knockoutp38 Mitogen-Activated Protein KinasesBromodeoxyuridineEstradiolIdb4 protein, mouseInhibitor of Differentiation Proteinsp38 Mitogen-Activated Protein KinasesProgesterone

Identifiers

PMID22069192
PMCPMC3210500
OpenAlexW2166487539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.